Clinical Trial Update: Observational, Bi-directional (Prospective and Retrospective) Study for Patients With Newly Diagnosed Ovarian Cancer Stages IA to IVB, or Persistent or Recurrent Disease From January 2021; Irrespective of Histology

View source ↗

Summary

An observational bi-directional study (prospective and retrospective) enrolling patients with newly diagnosed ovarian cancer (stages IA-IVB) or persistent/recur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: AstraZeneca | Conditions: Ovarian Cancer | Status: RECRUITING